Vidal Sassoon salons
This article was originally published in The Rose Sheet
Executive Summary
Regis Corporation acquires 25 Vidal Sassoon salons and four Vidal Sassoon beauty academies from Haircare Limited and has assumed licensing agreement with Procter & Gamble to expand salon group in North America, the UK and Germany, Minneapolis firm announces. Acquisition expected to add $25 mil. to Regis' revenue in fiscal 2003 and $49 mil. in fiscal 2004, firm adds. Procter & Gamble recently announced it was discontinuing the mass market Vidal Sassoon hair care collection in the near-term, but would consider repositioning it for a relaunch in the future (1"The Rose Sheet" Nov. 11, 2002, p. 7)...
You may also be interested in...
P&G Gives Hair Care Portfolio A Trim; VS Sassoon To Be Discontinued
Procter & Gamble will suspend its VS Sassoon hair care line in the U.S. due to declining sales, the company said. P&G plans to stop shipping the line early next year, but retailers are expected to sell through remaining stock, the firm stated
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.